Xtant Medical appoints Scott C. Neils as CFO effective June 1, 2022

Xtant Medical Holdings, Inc.

Annual base salary of $400,000; target bonus 50% of base, prorated for 2022.
Severance provides 12 months base salary + prorated bonus + 12 months COBRA if terminated without cause.
Double-trigger change-in-control severance: lump-sum payment of 12 months base salary.
Employment agreement includes 12-month non-compete and non-solicitation covenants.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Scott C. Neils

Chief Financial Officer

XTNT · Xtant Medical Holdings, Inc.

Effective: 2022-06-01
Filed: May 2, 2022, 7:59 PM ET

On April 27, 2022, the Board of Directors of Xtant Medical Holdings, Inc. (the “Company”) approved the appointment of Scott C. Neils as non-interim Chief Financial Officer, effective June 1, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Scott C. Neils was appointed as Chief Financial Officer at Xtant Medical Holdings, Inc..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On April 27, 2022, the Board of Directors of Xtant Medical Holdings, Inc. (the “Company”) approved the appointment of Scott C. Neils as non-interim Chief Financial Officer, effective June 1, 2022.

View on SEC.gov

Xtant Medical Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-22-011719

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.